Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Toxicology,Pharmacology,Immunology
Reference20 articles.
1. F. Ellouz, A. Adam, R. Ciorbaru and E. Lederer,Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun.59, 1317–1325 (1974).
2. S. Kotani, Y. Watanabe, F. Kinoshita, T. Shimono, T. Shiba, S. Kusumoto, Y. Tarumi and K. Ikenaka,Immunoadjuvant activities of synthetic N-acetylmuramyl-peptides or-amino acids. Biken J.18, 105–111 (1975).
3. K. Mašek, M. Zaoral, J. Ježek and V. Krchňák,Structure specificity of some immunoadjuvant synthetic glycopeptides. Experientia35, 1397–1398 (1979).
4. C. D. Leclerc, F. M. Audibert, L. A. Chedid, E. J. Deriaud, N. K. Masihi and E. Lederer,Comparison of immunomodulatory activities in mice and guinea pigs of a synthetic desmuramyl peptidolipid triglymyc. Infect. Immun.43, 870–875 (1984).
5. K. Šůla, Z. Zidek and K. Nouza,Effects of adamantylamide dipeptide (AdDP) on cell mediated immunity in vivo. InImmunotherapeutic Prospects of Infectious Diseases (Eds. K. N. Masihi and W. Lange) pp. 217–221, Springer, Berlin 1990.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献